325 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
was primarily due to decreases in compensation and other employee costs as a result of the restructuring initiatives that began during the first quarter
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
WEIL:\99660008\5\43717.0003 April [ ], 2024 NAME ADDRESS Via Email: XXX@ebsi.com RE: Amendment to Key Employee Retention Program Dear … [ ]: In recognition of your continuing key role at Emergent BioSolutions Inc. (the "Company"), you and the Company entered into a Key Employee Retention Program
8-K
EX-99.1
oq7ljq4vkc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
jr10wwk5db0pmx25eh
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
S-8 POS
3tzcvcwi
12 Dec 23
Registration of securities for employees (post-effective amendment)
7:05pm
S-8
yim6lymf4qves4
11 Dec 23
Registration of securities for employees
5:22pm
8-K
EX-99.1
o9okukw7n6r5 tq1
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-10.1
rt7 7pc9dj8duau0b3
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
8-K
swy0yqyp
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am